Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

342 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2023-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels \> and \< 1.1 ng/mL.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women

NCT03160872

Infertility

COMPLETED

Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks

NCT01887652

Infertility

COMPLETED NA

Conversion of in Vitro Fertilization Cycles to Intrauterine Inseminations in Patients With a Poor Ovarian Response to Stimulation

NCT03362489

Infertility

COMPLETED NA

Effect of Gonadotropin Types and Indications on Homologous Intrauterine Insemination Success

NCT03669276

Infertility

COMPLETED

Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins

NCT02237781

Female Infertility

UNKNOWN PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Female Anti-Mullerian Hormone Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AMH < 1.1 ng/ml

Intrauterine insemination

Intervention Type PROCEDURE

Intrauterine insemination with sperm donors

AMH > 1.1 ng/ml

Intrauterine insemination

Intervention Type PROCEDURE

Intrauterine insemination with sperm donors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intrauterine insemination

Intrauterine insemination with sperm donors

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* IUI cycles with sperm donors either due to severe oligoasthenoteratozoospermia in the partner (defined as a motile sperm count (MSC) \< 5 million in the ejaculate) or for social reasons, with up to 4 attempts accounted for.